Therapeutic response and safety of the topical, sequential use of antiseptic, keratolytic, and pentamidine creams (3-PACK) on Leishmania (Viannia) braziliensis-infected mice

Muñoz, Betsy Yaneth; Mantilla, Julio Cesar; Escobar, Patricia.
Mem. Inst. Oswaldo Cruz ; 114: e180535, 2019. tab, graf
Artículo en Inglés | LILACS | ID: biblio-1002683

Documentos relacionados

  1. 5-ALA-mediated photodynamic therapy reduces the parasite load in mice infected with Leishmania braziliensis.
  2. Distribution, treatment outcome and genetic diversity of Leishmania species in military personnel from Colombia with cutaneous leishmaniasis.
  3. DC-SIGN receptor is expressed by cells from cutaneous leishmaniasis lesions and differentially binds to Leishmania (Viannia) braziliensis and L. (Leishmania) amazonensis promastigotes.
  4. First report of Leishmania RNA virus 1 in Leishmania (Viannia) braziliensis clinical isolates from Rio de Janeiro State - Brazil.
  5. CXCL10 immunomodulatory effect against infection caused by an antimony refractory isolate of Leishmania braziliensis in mice.
  6. Selective whole-genome amplification reveals population genetics of Leishmania braziliensis directly from patient skin biopsies.
  7. Activity of synthetic chalcones in hamsters experimentally infected with Leishmania (Viannia) braziliensis.
  8. Topical 15% Paromomycin-Aquaphilic for Bolivian Leishmania braziliensis Cutaneous Leishmaniasis: A Randomized, Placebo-controlled Trial.
  9. Insights into the proteomic profile and gene expression of Lutzomyia longipalpis-derived Lulo cell line.
  10. Antigenic extracts of Leishmania braziliensis and Leishmania amazonensis associated with saponin partially protects BALB/c mice against Leishmania chagasi infection by suppressing IL-10 and IL-4 production.